ArticleEuropean journal of medical research2025
A prediction model for 30-day mortality in patients with ARDS admitted to the intensive care unit.
Article in European journal of medical research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Prognostic Value of Serial Lactate Dehydrogenase Measurements for Determining Early Mortality in ICU Patients: A Retrospective Cohort Study.Journal of clinical medicine · 2026Article
- Dysregulated metabolic homeostasis as a unifying death mechanism underlying the diverse clinical manifestations of COVID-19: insights from a retrospective analysis of sequential blood variables.Frontiers in medicine · 2026Article
- Global research trends in influenza-associated acute lung injury/acute respiratory distress syndrome: a bibliometric analysis from 2010 to 2024.Journal of thoracic disease · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe development of acute respiratory distress syndrome (ARDS) is intricate and uncertain. Although intensive care has made substantial progress in the past several decades, the in-hospital mortality rate of patients with ARDS remains as high as 40%, which imposes a large burden on hospitals and intensive care. This study aimed to develop and validate a nomogram to predict the 30-day mortality of patients with ARDS admitted in the intensive care unit (ICU).
methodsData of 4920 patients with ARDS were collected from the MIMIC-IV database, as well as data of 248 patients were collected from the Affiliated Hospital of Southwest Medical University. After processing these data, we performed correlation analysis between various types of variables and plotted a heat map to visualize the significance of these correlations. Subsequently, LASSO regression was used to initially screen for risk factors strongly associated with 30-day death in patients with ARDS, and a prediction model was established by multivariate logistic regression. The predictive efficacy of this model was preliminarily evaluated; internally validated; and compared with that of SOFA, APS-III, OASIS, and SAPS-II scores. In addition, it was externally validated using patient data from the ICU in China.
resultsThe AUC of the model was 0.78; The AUC values in the internal validation and external validation sets were 0.805 and 0.742, respectively. Moreover, the model demonstrated better predictive efficacy than this three traditional disease severity scoring systems (OASIS, SAPS-II, APS-III, and SOFA), highlighting its good predictive value.
conclusionsWe established a 30-day mortality risk prediction model for patients with ARDS who were first admitted to ICU by simple and easily accessible clinical data. To enhance real-world utility, we engineered an open-access mobile application that provides instant risk stratification at the bedside. This model synergizes with existing ICU scoring systems by enabling early identification of high-risk patients during initial assessment, thereby guiding timely interventions.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.